Last 12 months
Inside the activity.
0 purchase rows · 16 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 2 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 4 |
| Jun 2026 | 0 | 5 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 21, 2017 Filed Aug 23, 2017 20:45 UTC |
Brown JimPresident & COO
|
Exercise / conversionStock Settled Stock Appreciation Rights · Derivative | 4,360 | $0.00 Strike: $28.81 | $0.00 |
DisclosureSEC source: 0001179110-17-011777 · edgar.xml · derivative · entry 7 Brown Jim · CIK 0001555707 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,140 Underlying: Common Stock · 4,360 shares Expires 2018-03-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 21, 2017 Filed Aug 23, 2017 20:45 UTC |
Brown JimPresident & COO
|
SaleCommon Stock | 2,175 | $57.80 | $125,715.00 |
DisclosureSEC source: 0001179110-17-011777 · edgar.xml · nonDerivative · entry 2 Brown Jim · CIK 0001555707 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| August 21, 2017 Filed Aug 23, 2017 20:45 UTC |
Brown JimPresident & COO
|
Exercise / conversionCommon Stock | 2,175 | $28.81 | $62,661.75 |
DisclosureSEC source: 0001179110-17-011777 · edgar.xml · nonDerivative · entry 1 Brown Jim · CIK 0001555707 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,175 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The shares acquired resulted from reporting person's settlement of the stock-settled stock appreciation rights disclosed in Table-II Read SEC document |
| August 02, 2017 Filed Aug 2, 2017 21:39 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 14,533 | $56.71 | $824,154.80 |
DisclosureSEC source: 0001179110-17-010998 · edgar.xml · nonDerivative · entry 2 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,338,220 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 14, 2017. F4 · price: Weighted average price. Price range in multiple transactions was $56.15 to $57.40, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| August 02, 2017 Filed Aug 2, 2017 21:38 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 14,533 | $56.71 | $824,154.80 |
DisclosureSEC source: 0001179110-17-010997 · edgar.xml · nonDerivative · entry 2 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 12,338,220 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 14, 2017. F4 · price: Weighted average price. Price range in multiple transactions was $56.15 to $57.40, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F1 · ownership.nature: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| August 01, 2017 Filed Aug 2, 2017 21:39 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 25,467 | $56.52 | $1,439,351.55 |
DisclosureSEC source: 0001179110-17-010998 · edgar.xml · nonDerivative · entry 1 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,352,753 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 14, 2017. F3 · price: Weighted average price. Price range in multiple transactions was $56.10 to $57.20, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| August 01, 2017 Filed Aug 2, 2017 21:38 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 25,467 | $56.52 | $1,439,351.55 |
DisclosureSEC source: 0001179110-17-010997 · edgar.xml · nonDerivative · entry 1 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 12,352,753 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 14, 2017. F3 · price: Weighted average price. Price range in multiple transactions was $56.10 to $57.20, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F1 · ownership.nature: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| July 31, 2017 Filed Jul 31, 2017 21:46 UTC |
FULLER GILBERT ADirector
|
Exercise / conversionStock-Settled Stock Appreciation Rights · Derivative | 3,000 | $0.00 Strike: $28.81 | $0.00 |
DisclosureSEC source: 0001179110-17-010827 · edgar.xml · derivative · entry 3 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Underlying: Common Stock · 3 shares Expires 2018-06-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 31, 2017 Filed Jul 31, 2017 21:46 UTC |
FULLER GILBERT ADirector
|
SaleCommon Stock | 1,483 | $57.67 | $85,520.90 |
DisclosureSEC source: 0001179110-17-010827 · edgar.xml · nonDerivative · entry 2 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · price: Weighted average price. Price range in multiple transactions was $57.60 to $57.701, inclusive. Read SEC document |
| July 31, 2017 Filed Jul 31, 2017 21:46 UTC |
FULLER GILBERT ADirector
|
Exercise / conversionCommon Stock | 1,483 | $28.81 | $42,725.23 |
DisclosureSEC source: 0001179110-17-010827 · edgar.xml · nonDerivative · entry 1 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,483 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The shares acquired resulted from the reporting person's settlement of the stock-settled stock appreciation rights disclosed in Table II. Read SEC document |
| July 24, 2017 Filed Jul 26, 2017 17:35 UTC |
AUCIAUX ROBERTDirector
|
GrantDeferred Stock Unit · Derivative | 822 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-17-010677 · edgar.xml · derivative · entry 1 AUCIAUX ROBERT · CIK 0001203342 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,630 Underlying: Common Stock · 822 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Stock Unit ("DSU") represents the issuer's obligation to transfer one share of common stock in accordance with the terms of the deferred stock unit agreement pursuant to which the DSU's were granted. F1 · price: Each Deferred Stock Unit ("DSU") represents the issuer's obligation to transfer one share of common stock in accordance with the terms of the deferred stock unit agreement pursuant to which the DSU's were granted. F2 · derivative.exercise_date: Following termination of the undersigned's service on the issuer's Board of Directors, the issuer will distribute to the undersigned shares of common stock equal to the number of DSU's granted. F2 · derivative.expiration_date: Following termination of the undersigned's service on the issuer's Board of Directors, the issuer will distribute to the undersigned shares of common stock equal to the number of DSU's granted. Read SEC document |
| July 24, 2017 Filed Jul 26, 2017 17:34 UTC |
FULLER GILBERT ADirector
|
GrantDeferred Stock Unit · Derivative | 822 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-17-010676 · edgar.xml · derivative · entry 1 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,822 Underlying: Common Stock · 822 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Stock Unit ("DSU") represents the issuer's obligation to transfer one share of common stock in accordance with the terms of the deferred stock unit agreement pursuant to which the DSU's were granted. F1 · price: Each Deferred Stock Unit ("DSU") represents the issuer's obligation to transfer one share of common stock in accordance with the terms of the deferred stock unit agreement pursuant to which the DSU's were granted. F2 · derivative.exercise_date: Following termination of the undersigned's service on the issuer's Board of Directors, the issuer will distribute to the undersigned shares of common stock equal to the number of DSU's granted. F2 · derivative.expiration_date: Following termination of the undersigned's service on the issuer's Board of Directors, the issuer will distribute to the undersigned shares of common stock equal to the number of DSU's granted. Read SEC document |
| July 05, 2017 Filed Jul 6, 2017 18:09 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 18,331 | $64.11 | $1,175,220.57 |
DisclosureSEC source: 0001179110-17-010162 · edgar.xml · nonDerivative · entry 2 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,378,220 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 14, 2017. F4 · price: Weighted average price. Price range in multiple transactions was $63.68 to $64.70, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| July 05, 2017 Filed Jul 6, 2017 18:09 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 18,331 | $64.11 | $1,175,220.57 |
DisclosureSEC source: 0001179110-17-010161 · edgar.xml · nonDerivative · entry 2 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 12,378,220 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 14, 2017. F4 · price: Weighted average price. Price range in multiple transactions was $63.68 to $64.70, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F1 · ownership.nature: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| July 03, 2017 Filed Jul 6, 2017 18:09 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 21,669 | $64.18 | $1,390,701.25 |
DisclosureSEC source: 0001179110-17-010162 · edgar.xml · nonDerivative · entry 1 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,396,551 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 14, 2017. F3 · price: Weighted average price. Price range in multiple transactions was $64.00 to $64.55, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| July 03, 2017 Filed Jul 6, 2017 18:09 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 21,669 | $64.18 | $1,390,701.25 |
DisclosureSEC source: 0001179110-17-010161 · edgar.xml · nonDerivative · entry 1 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 12,396,551 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 14, 2017. F3 · price: Weighted average price. Price range in multiple transactions was $64.00 to $64.55, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F1 · ownership.nature: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| June 02, 2017 Filed Jun 2, 2017 21:24 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 13,731 | $65.30 | $896,617.82 |
DisclosureSEC source: 0001179110-17-008459 · edgar.xml · nonDerivative · entry 2 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,418,220 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 14, 2017. F4 · price: Weighted average price. Price range in multiple transactions was $64.75 to $65.80, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| June 02, 2017 Filed Jun 2, 2017 21:24 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 13,731 | $65.30 | $896,617.82 |
DisclosureSEC source: 0001179110-17-008458 · edgar.xml · nonDerivative · entry 2 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 12,418,220 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 14, 2017. F4 · price: Weighted average price. Price range in multiple transactions was $64.75 to $65.80, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F1 · ownership.nature: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| June 01, 2017 Filed Jun 1, 2017 16:55 UTC |
Jones Paul A.Chief Leadership Devlop Office
|
Exercise / conversionStock Settled Stock Appreciation Rights · Derivative | 877 | $0.00 Strike: $19.12 | $0.00 |
DisclosureSEC source: 0001179110-17-008291 · edgar.xml · derivative · entry 9 Jones Paul A. · CIK 0001565541 · Chief Leadership Devlop Office 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,000 Underlying: Common Stock · 877 shares Expires 2018-06-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2017 Filed Jun 1, 2017 16:55 UTC |
Jones Paul A.Chief Leadership Devlop Office
|
SaleCommon Stock | 618 | $64.50 | $39,861.00 |
DisclosureSEC source: 0001179110-17-008291 · edgar.xml · nonDerivative · entry 6 Jones Paul A. · CIK 0001565541 · Chief Leadership Devlop Office 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| June 01, 2017 Filed Jun 1, 2017 16:55 UTC |
Jones Paul A.Chief Leadership Devlop Office
|
Exercise / conversionCommon Stock | 618 | $19.12 | $11,813.07 |
DisclosureSEC source: 0001179110-17-008291 · edgar.xml · nonDerivative · entry 5 Jones Paul A. · CIK 0001565541 · Chief Leadership Devlop Office 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 618 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The shares acquired resulted from reporting person's settlement of the stock-settled stock appreciation rights disclosed in Table-II Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 21:24 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 26,269 | $64.82 | $1,702,824.88 |
DisclosureSEC source: 0001179110-17-008459 · edgar.xml · nonDerivative · entry 1 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,431,951 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 14, 2017. F3 · price: Weighted average price. Price range in multiple transactions was $64.13 to $65.20, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 21:24 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 26,269 | $64.82 | $1,702,824.88 |
DisclosureSEC source: 0001179110-17-008458 · edgar.xml · nonDerivative · entry 1 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 12,431,951 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 14, 2017. F3 · price: Weighted average price. Price range in multiple transactions was $64.13 to $65.20, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F1 · ownership.nature: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| May 31, 2017 Filed Jun 1, 2017 16:55 UTC |
Jones Paul A.Chief Leadership Devlop Office
|
Exercise / conversionStock Settled Stock Appreciation Rights · Derivative | 4,567 | $0.00 Strike: $19.12 | $0.00 |
DisclosureSEC source: 0001179110-17-008291 · edgar.xml · derivative · entry 8 Jones Paul A. · CIK 0001565541 · Chief Leadership Devlop Office 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,877 Underlying: Common Stock · 4,567 shares Expires 2018-06-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 31, 2017 Filed Jun 1, 2017 16:55 UTC |
Jones Paul A.Chief Leadership Devlop Office
|
SaleCommon Stock | 3,213 | $64.50 | $207,238.50 |
DisclosureSEC source: 0001179110-17-008291 · edgar.xml · nonDerivative · entry 4 Jones Paul A. · CIK 0001565541 · Chief Leadership Devlop Office 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| May 31, 2017 Filed Jun 1, 2017 16:55 UTC |
Jones Paul A.Chief Leadership Devlop Office
|
Exercise / conversionCommon Stock | 3,213 | $19.12 | $61,416.50 |
DisclosureSEC source: 0001179110-17-008291 · edgar.xml · nonDerivative · entry 3 Jones Paul A. · CIK 0001565541 · Chief Leadership Devlop Office 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,213 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The shares acquired resulted from reporting person's settlement of the stock-settled stock appreciation rights disclosed in Table-II Read SEC document |
| May 30, 2017 Filed Jun 1, 2017 16:55 UTC |
Jones Paul A.Chief Leadership Devlop Office
|
Exercise / conversionStock Settled Stock Appreciation Rights · Derivative | 8,556 | $0.00 Strike: $19.12 | $0.00 |
DisclosureSEC source: 0001179110-17-008291 · edgar.xml · derivative · entry 7 Jones Paul A. · CIK 0001565541 · Chief Leadership Devlop Office 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,444 Underlying: Common Stock · 8,556 shares Expires 2018-06-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 30, 2017 Filed Jun 1, 2017 16:55 UTC |
Jones Paul A.Chief Leadership Devlop Office
|
SaleCommon Stock | 6,020 | $64.50 | $388,290.00 |
DisclosureSEC source: 0001179110-17-008291 · edgar.xml · nonDerivative · entry 2 Jones Paul A. · CIK 0001565541 · Chief Leadership Devlop Office 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| May 30, 2017 Filed Jun 1, 2017 16:55 UTC |
Jones Paul A.Chief Leadership Devlop Office
|
Exercise / conversionCommon Stock | 6,020 | $19.12 | $115,072.30 |
DisclosureSEC source: 0001179110-17-008291 · edgar.xml · nonDerivative · entry 1 Jones Paul A. · CIK 0001565541 · Chief Leadership Devlop Office 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,020 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The shares acquired resulted from reporting person's settlement of the stock-settled stock appreciation rights disclosed in Table-II Read SEC document |
| May 11, 2017 Filed May 12, 2017 16:21 UTC |
FULLER GILBERT ADirector
|
Exercise / conversionStock-Settled Stock Appreciation Rights · Derivative | 9,000 | $0.00 Strike: $28.81 | $0.00 |
DisclosureSEC source: 0001179110-17-007096 · edgar.xml · derivative · entry 3 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 9,000 shares Expires 2018-06-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 11, 2017 Filed May 12, 2017 16:21 UTC |
FULLER GILBERT ADirector
|
SaleCommon Stock | 4,884 | $64.38 | $314,454.87 |
DisclosureSEC source: 0001179110-17-007096 · edgar.xml · nonDerivative · entry 2 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · price: Weighted average price. Price range in multiple transactions was $64.15 to $64.50, inclusive. Read SEC document |
| May 11, 2017 Filed May 12, 2017 16:21 UTC |
FULLER GILBERT ADirector
|
Exercise / conversionCommon Stock | 4,884 | $28.81 | $140,708.04 |
DisclosureSEC source: 0001179110-17-007096 · edgar.xml · nonDerivative · entry 1 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,884 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The shares acquired resulted from the reporting person's settlement of the stock-settled stock appreciation rights disclosed in Table II. Read SEC document |
| May 01, 2017 Filed May 3, 2017 21:45 UTC |
Brown JimPresident & COO
|
GrantRestricted Stock Units · Derivative | 5,493 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-006495 · edgar.xml · derivative · entry 1 Brown Jim · CIK 0001555707 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,993 Underlying: Common Stock · 5,493 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F2 · derivative.exercise_date: Restricted Stock Units vest 25% on the anniversary of February 6th, 2017. F2 · derivative.expiration_date: Restricted Stock Units vest 25% on the anniversary of February 6th, 2017. Read SEC document |
| May 01, 2017 Filed May 3, 2017 21:44 UTC |
Guest KevinC.E.O.
|
GrantRestricted Stock Units · Derivative | 5,493 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-006494 · edgar.xml · derivative · entry 1 Guest Kevin · CIK 0001353496 · C.E.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 183,993 Underlying: Common Stock · 5,493 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock F2 · derivative.exercise_date: Restricted Stock Units vest 25% on the anniversary of February 6th, 2017. F2 · derivative.expiration_date: Restricted Stock Units vest 25% on the anniversary of February 6th, 2017. Read SEC document |
| May 01, 2017 Filed May 3, 2017 21:44 UTC |
Macuga Daniel A.Chief Communications Officer
|
GrantRestricted Stock Units · Derivative | 3,492 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-006493 · edgar.xml · derivative · entry 1 Macuga Daniel A. · CIK 0001537768 · Chief Communications Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,992 Underlying: Common Stock · 3,492 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F2 · derivative.exercise_date: Restricted Stock Units vest 25% on the anniversary of February 6th, 2017. F2 · derivative.expiration_date: Restricted Stock Units vest 25% on the anniversary of February 6th, 2017. Read SEC document |
| May 01, 2017 Filed May 3, 2017 21:43 UTC |
Mulham David MulhamChief Field Development Office
|
GrantRestricted Stock Units · Derivative | 3,492 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-006492 · edgar.xml · derivative · entry 1 Mulham David Mulham · CIK 0001697433 · Chief Field Development Office 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,492 Underlying: Common Stock · 3,492 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F2 · derivative.exercise_date: Restricted Stock Units vest 25% on the anniversary of February 6th, 2017. F2 · derivative.expiration_date: Restricted Stock Units vest 25% on the anniversary of February 6th, 2017. Read SEC document |
| May 01, 2017 Filed May 3, 2017 21:42 UTC |
Peng FengDirector
|
GrantDeferred Stock Unit · Derivative | 1,880 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-17-006491 · edgar.xml · derivative · entry 1 Peng Feng · CIK 0001673696 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,660 Underlying: Common Stock · 1,880 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Stock Unit ("DSU") represents the issuer's obligation to transfer one share of common stock in accordance with the terms of the deferred stock unit agreement pursuant to which the DSU's were granted. F1 · price: Each Deferred Stock Unit ("DSU") represents the issuer's obligation to transfer one share of common stock in accordance with the terms of the deferred stock unit agreement pursuant to which the DSU's were granted. F2 · derivative.exercise_date: Following termination of the undersigned's service on the issuer's Board of Directors, the issuer will distribute to the undersigned shares of common stock equal to the number of DSU's granted. F2 · derivative.expiration_date: Following termination of the undersigned's service on the issuer's Board of Directors, the issuer will distribute to the undersigned shares of common stock equal to the number of DSU's granted. Read SEC document |
| May 01, 2017 Filed May 3, 2017 21:42 UTC |
Williams Donald R.Director
|
GrantDeferred Stock Unit · Derivative | 1,880 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-17-006490 · edgar.xml · derivative · entry 1 Williams Donald R. · CIK 0001487159 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,660 Underlying: Common Stock · 1,880 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Stock Unit ("DSU") represents the issuer's obligation to transfer one share of common stock in accordance with the terms of the deferred stock unit agreement pursuant to which the DSU's were granted. F1 · price: Each Deferred Stock Unit ("DSU") represents the issuer's obligation to transfer one share of common stock in accordance with the terms of the deferred stock unit agreement pursuant to which the DSU's were granted. F2 · derivative.exercise_date: Following termination of the undersigned's service on the issuer's Board of Directors, the issuer will distribute to the undersigned shares of common stock equal to the number of DSU's granted. F2 · derivative.expiration_date: Following termination of the undersigned's service on the issuer's Board of Directors, the issuer will distribute to the undersigned shares of common stock equal to the number of DSU's granted. Read SEC document |
| May 01, 2017 Filed May 3, 2017 21:40 UTC |
Winssinger Frederic JDirector
|
GrantDeferred Stock Unit · Derivative | 1,880 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-17-006489 · edgar.xml · derivative · entry 1 Winssinger Frederic J · CIK 0001673356 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,660 Underlying: Common Stock · 1,880 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Stock Unit ("DSU") represents the issuer's obligation to transfer one share of common stock in accordance with the terms of the deferred stock unit agreement pursuant to which the DSU's were granted. F1 · price: Each Deferred Stock Unit ("DSU") represents the issuer's obligation to transfer one share of common stock in accordance with the terms of the deferred stock unit agreement pursuant to which the DSU's were granted. F2 · derivative.exercise_date: Following termination of the undersigned's service on the issuer's Board of Directors, the issuer will distribute to the undersigned shares of common stock equal to the number of DSU's granted. F2 · derivative.expiration_date: Following termination of the undersigned's service on the issuer's Board of Directors, the issuer will distribute to the undersigned shares of common stock equal to the number of DSU's granted. Read SEC document |
| May 01, 2017 Filed May 3, 2017 14:06 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 40,000 | $56.39 | $2,255,728.00 |
DisclosureSEC source: 0001179110-17-006449 · edgar.xml · nonDerivative · entry 1 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,458,220 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 14, 2017. F3 · price: Weighted average price. Price range in multiple transactions was $55.20 to $57.05, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| May 01, 2017 Filed May 3, 2017 14:05 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 40,000 | $56.39 | $2,255,728.00 |
DisclosureSEC source: 0001179110-17-006448 · edgar.xml · nonDerivative · entry 1 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 12,458,220 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 14, 2017. F3 · price: Weighted average price. Price range in multiple transactions was $55.20 to $57.05, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F1 · ownership.nature: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| April 05, 2017 Filed Apr 5, 2017 21:09 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 16,436 | $56.54 | $929,214.19 |
DisclosureSEC source: 0001179110-17-005786 · edgar.xml · nonDerivative · entry 3 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,498,220 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 14, 2017. F5 · price: Weighted average price. Price range in multiple transactions was $55.65 to $57.15, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| April 05, 2017 Filed Apr 5, 2017 21:09 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 16,436 | $56.54 | $929,214.19 |
DisclosureSEC source: 0001179110-17-005785 · edgar.xml · nonDerivative · entry 3 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 12,498,220 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 14, 2017. F5 · price: Weighted average price. Price range in multiple transactions was $55.65 to $57.15, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth F1 · ownership.nature: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| April 04, 2017 Filed Apr 5, 2017 21:09 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 10,040 | $56.69 | $569,168.60 |
DisclosureSEC source: 0001179110-17-005786 · edgar.xml · nonDerivative · entry 2 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,514,656 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 14, 2017. F4 · price: Weighted average price. Price range in multiple transactions was $56.10 to $57.20, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| April 04, 2017 Filed Apr 5, 2017 21:09 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 10,040 | $56.69 | $569,168.60 |
DisclosureSEC source: 0001179110-17-005785 · edgar.xml · nonDerivative · entry 2 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 12,514,656 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 14, 2017. F4 · price: Weighted average price. Price range in multiple transactions was $56.10 to $57.20, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth F1 · ownership.nature: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| April 03, 2017 Filed Apr 5, 2017 21:09 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 13,524 | $57.22 | $773,898.73 |
DisclosureSEC source: 0001179110-17-005786 · edgar.xml · nonDerivative · entry 1 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,524,696 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 14, 2017. F3 · price: Weighted average price. Price range in multiple transactions was $56.65 to $57.65, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| April 03, 2017 Filed Apr 5, 2017 21:09 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 13,524 | $57.22 | $773,898.73 |
DisclosureSEC source: 0001179110-17-005785 · edgar.xml · nonDerivative · entry 1 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 12,524,696 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 14, 2017. F3 · price: Weighted average price. Price range in multiple transactions was $56.65 to $57.65, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F1 · ownership.nature: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| March 08, 2017 Filed Mar 9, 2017 16:48 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 20,000 | $57.15 | $1,143,014.00 |
DisclosureSEC source: 0001179110-17-004293 · edgar.xml · nonDerivative · entry 1 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 12,538,220 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2015. F3 · price: Weighted average price. Price range in multiple transactions was $56.975 to $57.65, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F1 · ownership.nature: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| March 08, 2017 Filed Mar 9, 2017 16:47 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 20,000 | $57.15 | $1,143,014.00 |
DisclosureSEC source: 0001179110-17-004292 · edgar.xml · nonDerivative · entry 1 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,538,220 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2015. F3 · price: Weighted average price. Price range in multiple transactions was $56.975 to $57.65, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| February 08, 2017 Filed Feb 9, 2017 14:49 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 20,000 | $55.87 | $1,117,344.00 |
DisclosureSEC source: 0001179110-17-002014 · edgar.xml · nonDerivative · entry 1 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 12,558,220 F1 · shares: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2015. F3 · price: Weighted average price. Price range in multiple transactions was $54.60 to $58.10, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F1 · ownership.nature: The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.